122 related articles for article (PubMed ID: 37832478)
1. The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations.
Luo D; Shi CY; Wei NS; Yang BY; Qin K; Liu G; Dong BQ; Qin YX; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Li H; Li J
Tuberculosis (Edinb); 2023 Dec; 143():102413. PubMed ID: 37832478
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis.
Huang Y; Tang JH; Cai Z; Qi Y; Jiang S; Ma TT; Yue Y; Huang F; Yang H; Ma YY
Tuberculosis (Edinb); 2022 Sep; 136():102231. PubMed ID: 35964506
[TBL] [Abstract][Full Text] [Related]
3. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
[TBL] [Abstract][Full Text] [Related]
4. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the intestinal microbiota associated with active tuberculosis and latent tuberculosis infection.
Huang Y; Tang J; Cai Z; Qi Y; Jiang S; Ma T; Yue Y; Huang F; Yang H; Ma Y
Heliyon; 2023 Nov; 9(11):e22124. PubMed ID: 38045157
[TBL] [Abstract][Full Text] [Related]
6. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
7. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
8. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
9. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
[TBL] [Abstract][Full Text] [Related]
10. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis.
Ma S; Peng P; Duan Z; Fan Y; Li X
J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
12. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
13. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
14. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
[TBL] [Abstract][Full Text] [Related]
15. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review on Novel
Meier NR; Jacobsen M; Ottenhoff THM; Ritz N
Front Immunol; 2018; 9():2476. PubMed ID: 30473692
[No Abstract] [Full Text] [Related]
17. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
[TBL] [Abstract][Full Text] [Related]
19. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
[TBL] [Abstract][Full Text] [Related]
20. Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection.
Xi X; Wang B; Zhang R; Ling C
J Microbiol Methods; 2024 Jul; 222():106944. PubMed ID: 38705210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
